BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10837225)

  • 1. The cyclin-dependent kinase Cdk5 controls multiple aspects of axon patterning in vivo.
    Connell-Crowley L; Le Gall M; Vo DJ; Giniger E
    Curr Biol; 2000 May; 10(10):599-602. PubMed ID: 10837225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cyclin-dependent kinase 5 and its activator P35 in local axon and growth cone stabilization.
    Hahn CM; Kleinholz H; Koester MP; Grieser S; Thelen K; Pollerberg GE
    Neuroscience; 2005; 134(2):449-65. PubMed ID: 15964697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice.
    Hallows JL; Chen K; DePinho RA; Vincent I
    J Neurosci; 2003 Nov; 23(33):10633-44. PubMed ID: 14627648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway.
    Patrick GN; Zhou P; Kwon YT; Howley PM; Tsai LH
    J Biol Chem; 1998 Sep; 273(37):24057-64. PubMed ID: 9727024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity.
    Nikolic M; Chou MM; Lu W; Mayer BJ; Tsai LH
    Nature; 1998 Sep; 395(6698):194-8. PubMed ID: 9744280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drosophila lacking the Cdk5 activator, p35, display defective axon guidance, age-dependent behavioral deficits and reduced lifespan.
    Connell-Crowley L; Vo D; Luke L; Giniger E
    Mech Dev; 2007 May; 124(5):341-9. PubMed ID: 17368005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation.
    Nikolic M; Dudek H; Kwon YT; Ramos YF; Tsai LH
    Genes Dev; 1996 Apr; 10(7):816-25. PubMed ID: 8846918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p35/cyclin-dependent kinase 5 phosphorylation of ras guanine nucleotide releasing factor 2 (RasGRF2) mediates Rac-dependent Extracellular Signal-regulated kinase 1/2 activity, altering RasGRF2 and microtubule-associated protein 1b distribution in neurons.
    Kesavapany S; Amin N; Zheng YL; Nijhara R; Jaffe H; Sihag R; Gutkind JS; Takahashi S; Kulkarni A; Grant P; Pant HC
    J Neurosci; 2004 May; 24(18):4421-31. PubMed ID: 15128856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic contributions of cyclin-dependant kinase 5/p35 and Reelin/Dab1 to the positioning of cortical neurons in the developing mouse brain.
    Ohshima T; Ogawa M; Veeranna ; Hirasawa M; Longenecker G; Ishiguro K; Pant HC; Brady RO; Kulkarni AB; Mikoshiba K
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2764-9. PubMed ID: 11226314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase.
    Kwon YT; Gupta A; Zhou Y; Nikolic M; Tsai LH
    Curr Biol; 2000 Apr; 10(7):363-72. PubMed ID: 10753743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism.
    Grant P; Sharma P; Pant HC
    Eur J Biochem; 2001 Mar; 268(6):1534-46. PubMed ID: 11248670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S; Saito T
    Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells.
    Lee JH; Kim KT
    J Neurochem; 2004 Nov; 91(3):634-47. PubMed ID: 15485494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of Pak1 by the p35/Cdk5 kinase affects neuronal morphology.
    Rashid T; Banerjee M; Nikolic M
    J Biol Chem; 2001 Dec; 276(52):49043-52. PubMed ID: 11604394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha2-chimaerin, cyclin-dependent Kinase 5/p35, and its target collapsin response mediator protein-2 are essential components in semaphorin 3A-induced growth-cone collapse.
    Brown M; Jacobs T; Eickholt B; Ferrari G; Teo M; Monfries C; Qi RZ; Leung T; Lim L; Hall C
    J Neurosci; 2004 Oct; 24(41):8994-9004. PubMed ID: 15483118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin dependent kinase 5 and its interacting proteins in cell death induced in vivo by cyclophosphamide in developing mouse embryos.
    Zhu Y; Lin L; Kim S; Quaglino D; Lockshin RA; Zakeri Z
    Cell Death Differ; 2002 Apr; 9(4):421-30. PubMed ID: 11965495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology.
    Maccioni RB; Otth C; Concha II; Muñoz JP
    Eur J Biochem; 2001 Mar; 268(6):1518-27. PubMed ID: 11248668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nestin Selectively Facilitates the Phosphorylation of the Lissencephaly-Linked Protein Doublecortin (DCX) by cdk5/p35 to Regulate Growth Cone Morphology and Sema3a Sensitivity in Developing Neurons.
    Bott CJ; McMahon LP; Keil JM; Yap CC; Kwan KY; Winckler B
    J Neurosci; 2020 May; 40(19):3720-3740. PubMed ID: 32273484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment.
    Ko J; Humbert S; Bronson RT; Takahashi S; Kulkarni AB; Li E; Tsai LH
    J Neurosci; 2001 Sep; 21(17):6758-71. PubMed ID: 11517264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the Cdk5--p35 kinase in neuronal development.
    Paglini G; Cáceres A
    Eur J Biochem; 2001 Mar; 268(6):1528-33. PubMed ID: 11248669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.